Preventive Cardiology
June 13, 2024
New Calculations Could Slash Statin-Eligible Population June 13, 2024
A JAMA paper suggests that if the CVD guidelines adopt the AHA’s new PREVENT cardiovascular risk equations, it might slash the US’s eligible preventive statin user population by nearly 40%.
Structural Heart
June 10, 2024
Edwards’ Strong Five-Year Small Annulus TAVR Outcomes June 10, 2024
Edwards and Medtronic’s fight for TAVR supremacy took an interesting turn last week, after Edwards showed that its SAPIEN 3 valve has similar five-year outcomes among patients with both small and large aortic annulus, regardless of their mean gradients and rates of prothesis-patient mismatch.
Artificial Intelligence
June 6, 2024
Philips Expands & Integrates Echo AI Platform June 6, 2024
Philips’ ultrasound AI strategy took another big step this week, with the launch of its next-generation echo AI platform, which will come integrated with the company’s cardiovascular ultrasound systems and bring a range of new echo-automating capabilities.
Preventive Cardiology
June 3, 2024
Preventive Statins Safe & Effective in Older Patients June 3, 2024
There is little consensus on whether or when to use statins for primary CVD prevention in older patients, but a new study provides compelling evidence for expanding statin use in this population.
Cardiology Practices
May 30, 2024
The Disappearance of Private Practice Cardiology May 30, 2024
In the not too distant past, the vast majority of cardiologists worked their entire careers in private practice, but a range of economic and administrative changes have driven around 70% of US cardiologists into hospital and corporate employment. In today’s issue, we’re diving into cardiology’s employment shift, and what the future holds for private practice cardiologists.
Electrophysiology
May 23, 2024
Cardiac Wire’s Top Six Takeaways from HRS 2024 May 23, 2024
The HRS 2024 meeting is now complete, after over 9,500 electrophysiology professionals converged in Boston to witness EP medicine evolve in front of their eyes. Among dozens of highlights, here are the Cardiac Wire’s six biggest trends emerging from HRS24.
Artificial Intelligence
May 20, 2024
AI Clearances Surge, Cardio AI Share Declines May 20, 2024
The FDA published its latest Healthcare AI Database last week, featuring a massive 882 AI-enabled medical device clearances, and highlighting some interesting trends in cardiovascular AI.
Heart Failure
May 16, 2024
Aficamten Shines in SEQUOIA-HCM Trial May 16, 2024
Cytokinetics’ obstructive hypertrophic cardiomyopathy drug aficamten excelled in its SEQUOIA-HCM Phase 3 trial, significantly improving peak oxygen uptake, while achieving all secondary effectiveness and safety endpoints.
Imaging
May 13, 2024
FFRCT Slashes PAD + CAD Mortality May 13, 2024
A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheral artery disease surgeries has a massive impact on coronary artery disease detection, treatments, and long-term outcomes.
Preventive Cardiology
May 9, 2024
America’s CKM Syndrome Problem May 9, 2024
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease.
Preventive Cardiology
May 2, 2024
Aspirin’s Lp(a) Primary Prevention Potential May 2, 2024
An observational study out of Emory suggests that aspirin could be the preventative Lp(a) treatment we’ve been looking for, finding that people with high Lp(a) levels who regularly take aspirin might significantly reduce their ASCVD mortality risks.
Heart Failure
April 29, 2024
Could Statins Be The Next Breakthrough HFpEF Treatment? April 29, 2024
A new JAMA study suggests that statins might have a massive impact on HFpEF care, even among patients who don’t have atherosclerosis.